☆ 4.6 Letter

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 96, Issue 1, Pages E5-+

Publisher

WILEY
DOI: 10.1002/ajh.26010

Keywords

-

Categories

Hematology

Funding

  1. Karyopharm Therapeutics, Newton, Massachusetts [NCT02336815]
  2. Karyopharm Therapeutics
  3. Good Publications Practice (GPP3) guidelines

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.